Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical

Recruiting

18 years - 99 years

All

Phase N/A

3 participants needed

1 Location

Brief description of study

The research study is being conducted to determine the safety and effectiveness of an investigational device, called the Edwards EVOQUE Replacement system (EVOQUE system) with Optimal Medical Therapy (OMT) compared to OMT alone for the treatment of tricuspid valve regurgitation (TR)

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Tricuspid regurgitation,Tricuspid regurgitation
Age: 18 years - 99 years
Gender: All

18 years of age Males and Female experiencing Tricuspid regurgitation

Updated on 04 Aug 2024. Study ID: 844681

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device

Brief description of study

Eligibility of study

Find a site

Interested in the study